[Insulin as vasoactive hormone. Significance for diabetes, obesity and hypertension].
Lind
L
L
Medicinska kliniken, Akademiska sjukhuset, Uppsala.
Berne
C
C
Andersson
P E
PE
Lithell
H
H
D002199:Capillary Permeability / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology*; D007328:Insulin / Q000378:metabolism / Q000502:physiology* / Q000627:therapeutic use; D009765:Obesity / Q000378:metabolism / Q000503:physiopathology*; D014665:Vasodilator Agents / Q000378:metabolism* / Q000627:therapeutic use
D007328:Insulin; D014665:Vasodilator Agents; D005947:Glucose